This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Aug 5;351(6):585-92.

doi: 10.1056/NEJMra035279.

Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

Biff F Palmer¹

Affiliations

PMID: 15295051
DOI: 10.1056/NEJMra035279

Review

Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

Biff F Palmer. N Engl J Med. 2004.

. 2004 Aug 5;351(6):585-92.

doi: 10.1056/NEJMra035279.

Author

Biff F Palmer¹

Affiliation

¹ Department of Medicine, Division of Nephrology, University of Texas Southwestern Medical School, Dallas 75390-8856, USA. biff.palmer@utsouthwestern.edu

PMID: 15295051
DOI: 10.1056/NEJMra035279

No abstract available

PubMed Disclaimer

Comment in

Hyperkalemia and inhibitors of the renin-angiotensin-aldosterone system.
Segal A. Segal A. N Engl J Med. 2004 Dec 2;351(23):2450-1; author reply 2450-1. doi: 10.1056/NEJM200412023512321. N Engl J Med. 2004. PMID: 15575066 No abstract available.

Similar articles

Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
Weir MR, Rolfe M. Weir MR, et al. Clin J Am Soc Nephrol. 2010 Mar;5(3):531-48. doi: 10.2215/CJN.07821109. Epub 2010 Feb 11. Clin J Am Soc Nephrol. 2010. PMID: 20150448 Review.
Hyperkalemia and inhibitors of the renin-angiotensin-aldosterone system.
Segal A. Segal A. N Engl J Med. 2004 Dec 2;351(23):2450-1; author reply 2450-1. doi: 10.1056/NEJM200412023512321. N Engl J Med. 2004. PMID: 15575066 No abstract available.
Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Raebel MA. Raebel MA. Cardiovasc Ther. 2012 Jun;30(3):e156-66. doi: 10.1111/j.1755-5922.2010.00258.x. Epub 2011 Jan 26. Cardiovasc Ther. 2012. PMID: 21883995 Review.
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises.
Palmer BF. Palmer BF. Nephrol Dial Transplant. 2003 Oct;18(10):1973-5. doi: 10.1093/ndt/gfg282. Nephrol Dial Transplant. 2003. PMID: 13679467 Review. No abstract available.
Increasingly restrictive definitions of hyperkalemia outcomes in a database study: effect on incidence estimates.
Raebel MA, Ross C, Cheetham C, Petersen H, Saylor G, Smith DH, Wright LA, Roblin DW, Xu S. Raebel MA, et al. Pharmacoepidemiol Drug Saf. 2010 Jan;19(1):19-25. doi: 10.1002/pds.1882. Pharmacoepidemiol Drug Saf. 2010. PMID: 19937982

See all similar articles

Cited by

Cardiovascular and Renal Outcomes Associated With Hyperkalemia in Chronic Kidney Disease: A Hospital-Based Cohort Study.
Kohsaka S, Okami S, Kanda E, Kashihara N, Yajima T. Kohsaka S, et al. Mayo Clin Proc Innov Qual Outcomes. 2021 Jan 19;5(2):274-285. doi: 10.1016/j.mayocpiqo.2020.10.001. eCollection 2021 Apr. Mayo Clin Proc Innov Qual Outcomes. 2021. PMID: 33997627 Free PMC article.
The Prevalence and Risk Factors of Hyperkalemia in the Outpatient Setting.
Sevamontree C, Jintajirapan S, Phakdeekitcharoen P, Phakdeekitcharoen B. Sevamontree C, et al. Int J Nephrol. 2024 Jan 22;2024:5694131. doi: 10.1155/2024/5694131. eCollection 2024. Int J Nephrol. 2024. PMID: 38292832 Free PMC article.
Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study.
Weir MA, Juurlink DN, Gomes T, Mamdani M, Hackam DG, Jain AK, Garg AX. Weir MA, et al. Clin J Am Soc Nephrol. 2010 Sep;5(9):1544-51. doi: 10.2215/CJN.01970310. Epub 2010 Jul 1. Clin J Am Soc Nephrol. 2010. PMID: 20595693 Free PMC article.
Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization.
Desai NR, Rowan CG, Alvarez PJ, Fogli J, Toto RD. Desai NR, et al. PLoS One. 2020 Jan 7;15(1):e0226844. doi: 10.1371/journal.pone.0226844. eCollection 2020. PLoS One. 2020. PMID: 31910208 Free PMC article.
Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021.
Banerjee D, Winocour P, Chowdhury TA, De P, Wahba M, Montero R, Fogarty D, Frankel AH, Karalliedde J, Mark PB, Patel DC, Pokrajac A, Sharif A, Zac-Varghese S, Bain S, Dasgupta I; Association of British Clinical Diabetologists and The Renal Association. Banerjee D, et al. BMC Nephrol. 2022 Jan 3;23(1):9. doi: 10.1186/s12882-021-02587-5. BMC Nephrol. 2022. PMID: 34979961 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database